Estrovera - Safety
Article Index
Page 4 of 7
SafetyERr 731 has a long-term history that is free of serious adverse events*
- Recommended by healthcare professionals in Germany since 1993
- Multiple in vitro and in vivo studies for toxicology and metabolism demonstrate a high degree of predicted safety*8-12
- No clinically relevant changes in safety parameters—including gynecological findings, vital parameters, and laboratory safety parameters associated with treatment after 108 weeks of clinical observation*2
Unlike hormone therapies, ERr 731 does not contain estrogen
- The observed clinical benefits of ERr 731 appear to be related to modulation of ERβ as demonstrated in laboratory studies*8-12
- Siberian rhubarb is a vegetable like its relative—garden rhubarb (Rheum rhabarbarium)
- All active constituents of ERr 731 are identified as hydroxystilbenes (phytonutrients), primarily rhaponticin
- ERr 731 does not contain anthraquinones, which are constituents of medicinal rhubarb plants traditionally used to treat occasional constipation and have potential liver toxicity*
ERr 731 demonstrates selective affinity for ERβ, in endometrial tissue, which suggests a safer approach.*